FdaApplication
ANDA 202052
Identifiers
- fda_app_no: ANDA202052
Properties
| Property | Value |
|---|---|
| applicant_name | ORBION PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2014-12-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | EQ 40MG BASE | TABLET, DELAYED RELEASE;ORAL |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE;ORAL |
2 products